These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease. Alden EC; Lundt ES; Twohy EL; Christianson TJ; Kremers WK; Machulda MM; Jack CR; Knopman DS; Mielke MM; Petersen RC; Stricker NH Alzheimers Dement (Amst); 2022; 14(1):e12325. PubMed ID: 35860792 [TBL] [Abstract][Full Text] [Related]
63. Alzheimer's pathology targets distinct memory networks in the ageing brain. Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481 [TBL] [Abstract][Full Text] [Related]
64. Sex differences in episodic memory in early midlife: impact of reproductive aging. Rentz DM; Weiss BK; Jacobs EG; Cherkerzian S; Klibanski A; Remington A; Aizley H; Goldstein JM Menopause; 2017 Apr; 24(4):400-408. PubMed ID: 27824681 [TBL] [Abstract][Full Text] [Related]
65. Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults. Bangen KJ; Clark AL; Edmonds EC; Evangelista ND; Werhane ML; Thomas KR; Locano LE; Tran M; Zlatar ZZ; Nation DA; Bondi MW; Delano-Wood L Front Aging Neurosci; 2017; 9():181. PubMed ID: 28642699 [TBL] [Abstract][Full Text] [Related]
66. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals. Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580 [TBL] [Abstract][Full Text] [Related]
75. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals. Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843 [TBL] [Abstract][Full Text] [Related]
76. Usefulness of CogEvo, a computerized cognitive assessment and training tool, for distinguishing patients with mild Alzheimer's disease and mild cognitive impairment from cognitively normal older people. Takechi H; Yoshino H Geriatr Gerontol Int; 2021 Feb; 21(2):192-196. PubMed ID: 33336432 [TBL] [Abstract][Full Text] [Related]
77. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease. Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398 [TBL] [Abstract][Full Text] [Related]